Crystal structure refinements were performed on five Al-rich phlogopite-lM crystals (1.50 ~< AI 3+ ~< 1.97 atoms per formula unit) from skarns of the Predazzo and Monzoni Hills petrographic area (north-east Italy) with the aim of characterizing geometrical variation produced by A13+ increase. The charge imbalance was mostly compensated for by substitutions of highly charged cations in the octahedral sheet (AI 3+ and/or Fe 3+ for Mg2+). The refinements were carried out in the mean space group C21m and gave agreement values (R) between 0.025 and 0.030. For some additional crystals, only chemistry and/or unit cell parameters were determined. In all samples the tetrahe~a are more regular and larger than those previously reported in the literature for phlogopite crystals and the misfit between tetrahedral and octahedral sheets, produced by the increase in the tetrahedral edges, is mostly compensated for by the tetrahedral ring angle rotation cx (10.2 ~ ~< ~< 12.5~ whereas the octahedral sheet features seem affected only by local crystal-chemical variations.
Members of the roedderite-chayesite series in lamproites from Cancarix (SE Spain), crystallized from late magmatic residua under low PH20, high temperature (~ l l00~ oxidizing conditions. They exhibit the following main chemical variations: 0.14 ~< Na ~< 0.62 atoms per formula unit ( The 12-coordinated C site, located between two double rings of T1 tetrahedra, is occupied mainly by K and subordinately by Na. Furthermore, Na occupies the partially empty nine-fold coordinated B site which occurs both in the ideal (z = 0) and in a split-atom position along the c direction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.